Status:

COMPLETED

Study of an External Responsive Neurostimulator System on Epileptiform Activity

Lead Sponsor:

NeuroPace

Conditions:

Epilepsy

Eligibility:

All Genders

12+ years

Phase:

PHASE2

Brief Summary

This feasibility clinical investigation is designed to demonstrate that the NeuroPace external Responsive Neurostimulator (model eRNS-300) can safely deliver responsive electrical stimulation automati...

Detailed Description

The Automated Response to Spontaneous Epileptiform Activity using the External Responsive Neurostimulator (eRNS) system clinical investigation involves subjects who are undergoing intracranial monitor...

Eligibility Criteria

Inclusion

  • Subject is undergoing evaluation for epilepsy surgery in a manner consistent with the Surgery for Epilepsy, NIH Consensus Statement, 1990 Mar 19-21; 8(2); 1-20.
  • Subject is implanted with intracranial electrodes.
  • Subject is under constant medical supervision while implanted with the intracranial electrodes.
  • Subject is twelve (12) years of age or older.

Exclusion

  • Subject is pregnant.
  • Subject has a clinically significant or unstable medical condition that, in the opinion of the investigator, would make it inadvisable for the individual to participate.
  • Subject has a progressive central nervous system disease or serious acute or ongoing systemic illnesses.
  • Subject has an active psychosis, severe depression, suicidal ideation or psychiatric conditions associated with impaired judgment.
  • Subject is considered at high risk, for any reason, by any of the investigators.
  • Subject is implanted with a medical device that might interfere with the eRNS. (This includes, but is not limited to direct brain neurostimulators, pacemakers, implantable cardiac defibrillators, spinal cord stimulators, vagal nerve stimulators, cochlear implants)

Key Trial Info

Start Date :

March 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

March 1 2008

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT00158067

Start Date

March 1 2002

End Date

March 1 2008

Last Update

August 26 2010

Active Locations (5)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (5 locations)

1

Research Site

Scottsdale, Arizona, United States, 85259

2

Research Site

Augusta, Georgia, United States, 30912

3

Research Site

Baltimore, Maryland, United States, 21287

4

Research Site

Rochester, Minnesota, United States, 55905